Please select an option below to help us tailor your newsletter to best suit your content interests!
Dr. Jason Porter details groundbreaking research for KRAS-mutant NSCLC during a Targeted Oncology Community Case Forum. đ Explore the CodeBreaK 100 and CodeBreaK 200 studies, showing promising results and insights into new treatment strategies. Read more about the accelerated approval of new treatment options, and their impact on patients’ lives. Let’s revolutionize #LungCancer care together!… Read more »
Exciting News in Lung Cancer Treatment Dr. Jason Porter joins Dr. Maya Khalil, Dr. Brian Mitzman, and Dr. Rami Manochakian in discussing the strides made in improving patient outcomes with immunotherapy and targeted therapies for non-small cell lung cancer (NSCLC). The group talks about several new clinical trials demonstrating promising results for high… Read more »
This past weekend, Drs. Bradley Somer, Gregory Vidal, and Jason Porter hosted presentations at the Best of ASCO – Memphis Conference! This Post ASCO review showcased abstracts from highly rated presentations and the latest research in oncology education. Our physicians helped lead several discussions including: Dr. Jason Porter: – “Personalizing Treatment for Adult Patients with… Read more »
Exciting updates in GI Cancers! Dr. Axel Grothey from West Cancer Center shared groundbreaking insights at the Total Health Spring Oncology Review and Renew Conference. He highlighted major advancements in targeted therapies and precision medicine for GI cancers. Here are the key highlights: Gastro-Esophageal Junction (GEJ) Cancers: Dr. Grothey revealed a new biomarker, Claudin 18.2… Read more »
Geriatric Oncology is a strong field of interest for our Radiation Oncologist and Co-Director of Clinical Research, Dr. Noam VanderWalde. In this podcast, he discusses the importance of personalization for older cancer patients alongside Dr Akila Viswanathan (Johns Hopkins Medicine) and Dr Ben Movsas (Henry Ford Cancer Institute – Detroit). Click here to listen!
Here at West, we believe that diversity, equity, and inclusion are critical to reducing cancer disparities. On Friday, March 3, Dr. Gregory Vidal led a workshop called “Conversations for Change” aimed to encourage conversations about prevention, diagnosis, and treatment of cancer to primary care providers in our community. Discussions included: – Diagnostic Standards… Read more »
Our West family is excited to host the upcoming “Diversity, Equity, and Inclusion Conversations for Change” on Friday, March 3. Aimed to improve pathways for care and end disparities in our area, Dr. Gregory Vidal and several fellow West providers invite primary care providers to this collaborative meeting. Topics include: – Barriers to Access of Cancer Care… Read more »
Diversity, equity, and inclusion are critical to reducing cancer disparities. We believe everyone should have the ability to benefit from advancements in the prevention, diagnosis, and treatment of cancer. West Medical Oncologist, Dr. Gregory Vidal, will be hosting a “Conversation for Change” on Friday, March 3 for Primary Care Providers to discuss: – Diagnostic Standards for… Read more »
Study Will Assess Impact on Positive Margin Rates West Cancer Center is seeking patients with breast cancer who are undergoing breast-conserving surgery, or a âlumpectomy,â for potential participation in a clinical trial. Dr. Richard Fine, Dr. Michael Berry, and Dr. Richard Gilmore are the breast surgeons participating in this trial. Breast Surgeon, Dr. Richard Fine,… Read more »